There are 2 papers on fat-free mass loss in aging research: 1 trial and 1 observational study in people.
2 papers study it12 more mention it3 findings
See all 14 papers on fat-free mass loss
“less loss of fat-free mass and greater IGF-1 levels were associated with reduced mortality during the next 2 years”
- Human trial1
- Humans1
Interventions
22'-fucosyllactose
downin humans1
1 study
2'-fucosyllactose
downin humans1
2'-fucosyllactose decreases fat-free mass loss in humans with exercise and caloric restriction (−229 g vs −983 g).
“Additionally, there was evidence suggesting that the 2′-FL group was more successful in maintaining the fat-free mass (2′-FL: −229 g [−1250, 791], p = 0.652; PLA: −983 g [−2029, 63], p = 0.065).”
Human trialwith exercise and caloric restriction12 weeksn = 41
Nutrients
Intermittent energy restriction
downin humans1
1 study
Intermittent energy restriction
downin humans1
Intermittent energy restriction prevents fat-free mass loss in humans (carbohydrate refeed versus continuous energy restriction in resistance-trained individuals) (FFM change RF Δ0.4 kg vs CN Δ1.3 kg).
“A 2-day carbohydrate refeed preserves FFM, dryFFM, and RMR during energy restriction compared to continuous energy restriction in RT-individuals.”
Human trialcarbohydrate refeed versus continuous energy restriction in resistance-trained individualstwo consecutive days of elevated carbohydrate intake each week~25% caloric restriction7 weeksn = 27
Journal of functional morphology and kinesiology
Associations
1Mortality
upin humans1
1 study
Mortality
upin humans1
Fat-free mass loss is linked with a higher risk of mortality in humans (change in fat-free mass index over first 2 years; subset with 55 deaths).
“less loss of fat-free mass and greater IGF-1 levels were associated with reduced mortality during the next 2 years”
Humanschange in fat-free mass index over first 2 years; subset with 55 deaths2 years of change, 2 years of follow-upn = 398
The American journal of medicine